APA (7th ed.) Citation

Mukhin, K. Y., Pylaeva, O. A., & Bobylova, M. Y. (2016, August). THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT. Русский журнал детской неврологии.

Chicago Style (17th ed.) Citation

Mukhin, K. Yu., O. A. Pylaeva, and M. Yu Bobylova. "THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT." Русский журнал детской неврологии Aug. 2016.

MLA (9th ed.) Citation

Mukhin, K. Yu., et al. "THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT." Русский журнал детской неврологии, Aug. 2016.